COVID-19 Information

For CAP-Accredited Laboratories

  • The College of American Pathologists is advocating for pathologists and laboratories in the wake of the outbreak of the novel (new) coronavirus “SARS-CoV-2” and the disease it causes, “coronavirus disease 2019” (abbreviated “COVID-19”).
  • PrimeStore® MTM Releases Cyanide Gas When Exposed to Bleach. CMS and CDC share alert regarding PrimeStore® Molecular Transport Medium (MTM) – an approved transport media for COVID-19 diagnostic swab samples – advising it contains guanidine thiocyanate, which produces a chemical reaction releasing cyanide gas when exposed to bleach (sodium hypochlorite).
  • CAP Statement on the Current Role of Serologic Testing for SARS-CoV-2. CAP President Patrick Godbey, MD, FCAP issued a statement regarding the Current Role of Serologic Testing for SARS-CoV-2, as there are still significant unknowns with respect to SARS-CoV-2 antibody testing, ranging from uncertainty regarding the accuracy of many commercially available assays to the clinical significance of positive results.
  • CAP Survey of Accredited Laboratories Confirms COVID-19 Testing Challenges. The CAP surveyed directors of clinical laboratories nationwide regarding the rate of COVID-19 testing, key barriers to expanding testing, and the impact on pathologists and other laboratory professionals. The survey confirms that while clinical laboratories are expanding testing, over 60% of laboratory directors report difficulties in obtaining critical supplies needed to conduct COVID-19 testing. Download our survey findings briefRe-watch our Town Hall with CAP-Accredited Laboratories.
  • On April 30, 2020, the Centers for Medicare and Medicaid Services (CMS) issued resources for CLIA-certified laboratories outlining testing requirements for SARS-CoV-2. They provide information on:
    • The types of SARS-CoV-2 testing and FDA authorization/notification
    • CLIA certifications under which each test can be performed
    • An explanation of requirements under each testing scenario
    • Information for Medicare beneficiaries on testing services and coverage
  • The CAP is providing guidance for CAP-Accredited Laboratories to ensure availability of reliable testing for rapid detection of the agent that causes COVID-19.
  • Implementing a SARS-CoV-2 Test in Your Laboratory. The CAP clarifies and simplifies the rules of compliance so that you can efficiently and safely introduce testing in your laboratory to serve your patients during this public health emergency.
  • Best Practices for Using Biologic Safety Cabinets While Testing for COVID-19. During this evolving landscape of testing for the SARS-CoV-2 virus, employ proper standards for using a biologic safety cabinet.

CAP US Inspections

  • Your inspection will likely be delayed per current CMS guidance: CAP Inspections COVID-19 Update
  • Self-inspections: 30-day extension to all laboratories that have a self-inspection due by June 1, 2020

Resuming Routine US Inspections

Beginning later this month, the CAP will slowly resume conducting routine inspections. All inspections will be announced and prioritized based on several factors. These factors include the phase of reopening achieved by the state in which the laboratory and inspectors are located, any COVID outbreaks or hot spot activity in the area the laboratory or inspector are located, and other restrictions that may impact the inspectors’ ability to travel for the inspection.

For Laboratories Whose Inspection is Past the Anniversary Date OR in the Inspection Window

If your laboratory inspection is late due to the COVID-19 pandemic, rest assured your accreditation continues. You should have received a letter from the CAP documenting that your laboratory is still accredited and outlining actions the laboratory is expected to take to maintain ongoing compliance. If you have not received this letter, or need a new copy, please contact the us at

When it comes to scheduling your inspection, you will be contacted by your assigned team leader or a member of the CAP assignments staff to confirm planned inspection dates, number of team members, and any other requirements that may be in place at your facility for the inspection team. We will work with your assigned inspection team to complete your inspection as soon as it is practical and possible. 

For Laboratories Who Have Not Reached the Inspection Window

We will work with your assigned inspection team to complete your inspection within your inspection window as much as is practical and possible. Your inspection will be announced, and you will be contacted by your assigned team leader or a member of the CAP assignments staff to confirm planned inspection dates, number of team members, and any entry requirements that may be in place at your facility for the inspection team.

CAP Inspections Delayed Internationally

  • Self-inspections: 30-day extension to all laboratories that have a self-inspection due by June 1, 2020
  • Internationally, the CAP has postponed most scheduled and requested laboratory inspections at this time. Some inspections using regional inspection teams may begin occurring in areas where this is possible and practical. During this time, impacted laboratories will remain CAP accredited. Additionally, to maintain quality and safety during this time, impacted laboratories should continue proficiency testing (PT) participation and follow all CAP requirements.

For Inspection Teams and Laboratories Scheduled for Inspection

  • Your health and safety are of utmost importance to us during this time of uncertainty with the coronavirus outbreak and we are continuing to monitor the situation. We will update impacted laboratories and inspectors regarding rescheduling. We appreciate your patience.

For CAP PT Customers

New Serology PT Program for the Detection of Antibodies Against SARS‑CoV‑2. Learn more

New PT Program for the Detection of SARS CoV-2. Read more

New statement on Serologic Testing for SARS-CoV-2. View here

The CAP is committed to working with your laboratory to manage kit deliveries, stability concerns, and regulatory requirements, just to name a few. To date, the CAP has taken the following actions:

  • We are delaying some shipments.
    • We continue to monitor international restrictions and to hold shipments, when possible.
  • We are extending due dates, when possible.
    • The CAP will automatically extend due dates for international customers when shipments are released.

Shipping, Testing, and Due Date Information

For international customers
Shipping will resume to your laboratory as restrictions are lifted. Your laboratory will receive a CAPTracker when shipments resume; this is your primary indicator. The CAP will automatically extend due dates for international customers when shipments are released. If a shipping restriction is lifted, but a program is unable to ship (eg, the material has expired), your laboratory will receive an email from the CAP.

For all PT customers
If the due date for a program that your laboratory is enrolled in is approaching, please submit data at your earliest convenience by accessing your result form on via e-LAB Solutions Suite. If your laboratory is unable to complete testing, select one of the following exception codes on your result form to avoid penalty on your evaluation. You do not need to call the CAP to use either code.

  • Code 11 (Unable to analyze):
    Use code 11 to indicate your laboratory was or is closed due to the COVID-19 pandemic or was unable to analyze the specimens (eg, instrument not functioning, reagents not available).
  • Code 33 (Specimen unsatisfactory):
    Use code 33 to indicate your laboratory never received a kit, if a kit was delivered with unusable material (eg, specimens no longer stable), or if the CAP was unable to fulfill your replacement request.

Printed participant summaries and evaluations will continue to be mailed to laboratories, but they may be delayed.

For laboratories that may have limited staff or are temporarily closed, you will need to arrange to receive shipments that the CAP is unable to delay. 

Per the Centers for Medicare & Medicaid Services’ (CMS) Clinical Laboratory Improvement Amendments (CLIA) Laboratory Guidance During COVID-19 Public Health Emergency document, “in the event where a laboratory temporarily suspends performing a specific test due to staffing shortage, supply shortage, or reagent shortage:

  • The laboratory must document the timeframe during which the test is not being performed, and the reason therefore.
  • The laboratory must notify the inspecting agency and PT program within the timeframe of submitting PT results that it has ceased testing, and the reason therefore.
  • If the laboratory is still performing, or resumes such testing, and providing patient results, PT is still required and must be performed, as required by the CLIA regulations.” 

If your laboratory is currently unable to perform testing, hold the material and use it for alternative assessment when routine testing circumstances resume. If your laboratory is holding material for testing beyond the kit due date, use exception code 11 on your result form to indicate your laboratory was unable to analyze the specimens and document the reason in the Use of Other section. You do not need to call the CAP to use this code. 

For more information, please access the following:

COVID-19 Resources

  • COVID-19 fee-for-service autopsy list compiled by the CAP Autopsy Committee Review the list
  • COVID-19 Autopsy Guideline Statement from the CAP Autopsy Committee Read the Statement
  • A Remote sign-out of cases with Digital Pathology FAQs published. Read the FAQs
  • Subject matter experts from the Informatics Committee compile resources for COVID-19. Read more
  • The Cytopathology Committee offers some considerations for cytopathology services during COVID-19. Read the update
  • Transfusion, Apheresis and Cellular Therapy Committee provides information on concerns for the national blood supply. Read the update

Advocacy News and Legislative Alerts

Here is the latest action that the CAP has taken for its members on the legislative front:

More resources:

CAP Survey of Laboratories Confirms COVID-19 Testing Challenges, Supply Shortages, and Excess Capacity

CAP Supports Paycheck Protection Program Increase Act of 2020

CAP Requests Additional Funding for Paycheck Protection Program

CAP Answers to Your Questions about Small Business Assistance During COVID-19

States Waiving Licensure Requirements/Renewals

New flexibilities from the CMS include in-place testing for home and community-based settings

CAP secures remote work waiver from CMS for pathologists

COVID-19 - Remote Sign-Out Guidance

Letter from Congress asking HHS to give pathologists the remote work flexibility advocated for by the CAP

CAP Calls on Health Officials to Give Labs, Pathologists Greater Flexibility for COVID-19 Pandemic

Letter to the US Department of Health and Human Services

Practice Resources for Pathologists

We have complied resources for you and your practice to help ease the burden you face during the COVID-19 pandemic. 

The CAP’s COVID-19 Financial Assistance Programs Roundtable
Tuesday, April 28, 2020, at 1:00 pm CDT

View this timely CAP member-led virtual roundtable to gain a better understanding of key financial assistance programs made available by Congress and learn about:

  • Financial assistance programs available to pathologists
  • Tools developed by the CAP to assist you with applications
  • Downstream implications to consider when obtaining assistance

Watch now

We will continue to add resources as they become available. Any questions or feedback is welcome:

Financial Assistance Programs

For pathology practices, we recognize many pathologists have experienced a sudden loss in revenue due to a drop in anatomic pathology services and other difficulties. The Coronavirus Aid, Relief, and Economic Security (CARES) Act established several new programs and funding sources to help address these shortfalls, which are applicable to pathologists and their practices/laboratories. The Paycheck Protection Program and Health Care Enhancement Act provided additional funds.

  • Jonathan Myles, MD, FCAP, chair of the CAP’s Council on Government and Professional Affairs, reviews assistance programs available to pathologists in this CAPcast.
  • Links to resources for pathologists looking to obtain financial assistance can be found in the CAP’s FAQs about the SBA loans. The FAQs include information to let you know what is available from the CARES Act and other federal government programs.
  • Provide us with your feedback and additional questions about these financial programs at

CAP members address financial assistance during COVID-19

  • Matthew Foster, MD, FCAP
  • Theresa Emory, MD, FCAP

Medicare Accelerated and Advance Payment Program

UPDATE: On April 26, 2020, the Centers for Medicare & Medicaid Services (CMS) announced that it is suspending its advance payment program effective immediately. According to CMS, this decision was reached in part because of the $175 billion recently appropriate for health care provider relief payments. For more on the relief payments, see the “Direct Provider Relief” section below. For more on this CMS decision, read the agency press release online here.

The CARES Act and the CMS expanded the accelerated and advance payment program for Medicare participating physicians and other providers to ensure they have resources needed to combat COVID-19. The advance payments are not a grant, and recoupment begins 120 days after initial payment for all providers. Physicians billing under Part B will have 210 days from the date of the accelerated or advance payment was made to repay the balance. Interest attaches to any outstanding balance after this date.

Paycheck Protection Program

On April 24, 2020, President Trump signed into law legislation that provides additional funding for the Paycheck Protection Program (PPP). This program, created as part of the CARES Act, provides small businesses with a loan for the purposes of retaining employees. Physician practices with 500 or fewer employees, sole proprietors, independent contractors, and self-employed persons are eligible to apply. You can apply through any existing SBA 7(a) lender or through any federally insured depository institution, federally insured credit union, and Farm Credit System institution that is participating. The loan will be fully forgiven if the funds are used for payroll costs, interest on mortgages, rent, and utilities (at least 75% of the forgiven amount must have been used for payroll).

  • To help expedite the PPP application process, the CAP has developed an application roadmap to provide general guidance and a PPP worksheet for estimating eligible funding amounts when preparing to apply for a loan under the Paycheck Protection Program.

Loan Forgiveness: Paycheck Protection Program

If your practice received a Paycheck Protection Program (PPP) loan you may now apply for forgiveness of up to 100% of the loan amount. The Loan Forgiveness Application must be completed by October 31, 2020 and list how the funds were utilized. If they were utilized in compliance with the PPP requirements practices may be able to obtain 100% forgiveness. Once completed, this form should be submitted to your lender for consideration.

Emergency Economic Injury Disaster Loans (EIDL) and Loan Advance

A new economic injury emergency grant program provides up to $10,000 to small businesses and private nonprofits harmed by COVID-19 within three days of applying for an EIDL loan. Funds will be made available following a successful application. This loan advance will not have to be repaid.

The Small Business Administration (SBA) EIDL program provides loans of up to $2 million to small businesses with less than 500 employees (including sole proprietorships, independent contractors and self-employed persons) that are experiencing temporary loss of revenue as a result of COVID-19. 

More information is available on the SBA website.

Other SBA Loans and Debt Relief

The CARES Act also made available $17 billion is available for immediate relief to small businesses with non-disaster SBA loans, in particular 7(a), 504, and microloans. Under it, SBA will cover all loan payments on these SBA loans, including principal, interest, and fees, for six months.

Apply now for SBA loans. Small business guidance and loan resources are also available on the SBA website.

Direct Provider Relief

Congress has appropriated over $100 billion for a Provider Relief Fund to reimburse providers for lost revenues and increased expenses due to the coronavirus pandemic. Starting April 10, 2020, the Department of Health and Human Services (HHS) initiated delivery of $30 billion in relief funding to providers in proportion to their Medicare fee-for-service payments in 2019. Providers were not required to engage in any activity or apply for these funds, which do not have to be repaid. The funds were sent directly to providers in the same fashion other Medicare payments are normally sent to your practice. However, in order to retain these funds, practices are required to sign an attestation form and agree to certain terms and conditions. Not returning the payment within 45 days of receipt of payment will be viewed as acceptance of the terms and conditions.

Starting April 24, 2020, an additional $20 billion was made available to reconcile the initial payment (if any) so that the provider ultimately receives a proportion of a provider’s 2018 patient revenue. Only Medicare providers who have already received a payment from the Provider Relief Fund will be eligible to apply for this additional wave of funds.

The CAP has developed a FAQ guide for members with questions related to the Provider Relief Fund payment, available online here. Another short guide on the process of requesting or confirming additional funds is available online here. Visit for additional information.

Resources for Remote Working

CLIA regulations mandate that pathologists must perform diagnostic tests in CLIA-licensed facilities. But the CMS stated during this public health emergency, it will exercise enforcement discretion to ensure pathologists may review pathology slides remotely using these guidelines. The FDA released additional guidance regarding digital pathology devices used during the public health emergency.

CAP members address remote working during COVID-19

  • Anil Parwani, MD, PhD, MBA, FCAP
  • Liron Pantanowitz, MD, FCAP

Regulatory Relief During the COVID-19 Crisis

Members and staff from the CAP’s Council on Government and Professional Affairs have developed the following FAQs to help summarize regulatory and payment issues affecting pathologists during the COVID-19 pandemic.

Other Guidance

  • CPT Guidance: The CMS issued guidance to ensure coverage of COVID-19 diagnostic testing, including antibody testing, at no cost for those with private health insurance. Additionally, the AMA approved and revised COVID-19 CPT codes with critical input from the Pathology Coding Caucus, which is an advisory group to AMA CPT chaired by Ronald McLawhon, MD, FCAP. The AMA new COVID-19 CPT codes provide laboratories a more specific reporting mechanism for antibody tests for severe acute respiratory syndrome coronavirus 2.

Topic Center

Our thought leadership from a wide array of councils and committees have responded to the COVID-19 pandemic. Visit our topic center for essential information and guidance.

CAP Meetings, Events, and Education

Upcoming Webinars

  • Post COVID-COVID – Will We Be Better Prepared for Round Two?
    Thursday, June 25 2020; 2:00 PM - 3:00 PM (CT)
    The key objectives of this roundtable are to evaluate best practices of recovery in the immediate post-COVID crisis and propose a preparedness plan to sustain a resurgence of the pandemic.
    Learn more and register
  • Access all our webinars

Previous Webinars

  • You’ve Been Asked to Implement SARS-CoV-2 Antibody Testing: What You Need to Know 
    Learn about the CAP’s statement on the current role of serologic testing as well as the difference between the clinical impact of an antibody test result versus a molecular test result. 
    Access the webinar
  • Navigating Implementation of SARS-CoV-2 Testing in Your Laboratory
    This webinar covers what is required for verification and validation when bringing up a new test plus ongoing requirements for personnel and quality monitoring to keep the test running.
    Access the webinar

New Learning Opportunities for our Members

Rescheduled Learning Courses

Information on Events and Committee Meetings

  • If you are registered for an event, we will contact you with any changes. 
  • For CAP committee meetings, please contact your committee staff person for updates as to whether your meeting will be held virtually, postponed, or cancelled.
  • For the Pathologists Leadership Summit, the summit has been cancelled. Registrants, please visit Pathologists Leadership Summit for details and actions to take for cancelling hotel and airline reservations.

CAP in the News and on Social Media

CAP Officers/Members Address COVID-19 Issues

  • Jonathan Lai, MD
  • Justin Snow, MD, FCAP
  • Mary Fowkes, MD, PhD, FCAP

Twitter Chat Wrap-ups

How Pathologists Can Navigate COVID-19-Related Practice Management Challenges.

Recap of the discussion about the resources available to pathologists as we navigate the practice management-related challenges resulting from the impact of COVID-19. Hosted by Brian H. Le, MD, FCAP.

Ramping Up Your Lab’s COVID-19 Testing Capabilities: Best Practices & Lessons Learned Diagnosing 

Recap of the March 31, 2020 Twitter chat on challenges pathologists are facing, and overcoming, as more laboratories implement COVID-19 diagnostic testing. Hosted by ​CAP member Ziad El-Zaatari, MD. 

Diagnosing COVID-19: What Pathologists Need to Know Now

Recap of the March 10, 2020 Twitter chat focusing on what pathologists need to know about their role in diagnosing and treating patients suspected to have COVID-19. Hosted by ​CAP member Ziad El-Zaatari, MD.


Listen to COVID-19 experiences, guidance, and advice.

Using Proficiency Testing to Ensure Accurate SARS-CoV-2 Testing
Bobbi Pritt, MD, FCAP, who chairs the CAP’s Microbiology Committee, discusses what pathologists and laboratories need to know about SARS-CoV-2. Dr. Pritt and committee members were instrumental in designing the CAP’s proficiency testing program for SARS-CoV-2, the novel coronavirus.

Using Proficiency Testing to Ensure Accurate SARS-CoV-2 Testing

How the Federal Small Business Loan Program Can Help Pathology Practices
Jonathan Myles, MD, FCAP, who chairs the CAP’s Council on Government and Professional Affairs, explains how the federal small business loan program can help pathologists keep their practices solvent until the pandemic and national emergency are over.

How the Federal Small Business Loan Program Can Help Pathology Practices

Diagnosing COVID-19: How OHSU Pathologists Launched Testing in 15 Days
In this CAPcast interview, Richard Scanlan, MD, FCAP discusses his experiences bringing COVID-19 testing online at his institution, including some lessons learned. Dr. Scanlan is the medical director of the Oregon Health and Sciences University Hospital laboratory in Portland, Oregon.

Diagnosing COVID-19: How OHSU Pathologists Launched Testing in 15 Days

CAPcast: Diagnosing COVID-19: Advice from UW Pathologists on Ramping Up Testing Capacity
Seattle experienced the COVID-19 pandemic’s first wave in the United States. UW Medicine’s Geoffrey Baird, MD, PhD, acting chair of Laboratory Medicine was at the forefront, confronting significant challenges related to diagnosing patients with this virus. In this CAPcast, Dr. Baird discusses lessons learned from testing and personnel challenges when ramping up testing capacity. In addition, Suzanne Dintzis, MD, PhD, FCAP, Associate Professor of Pathology at UW School of Medicine and current president of the Washington State Society of Pathologists, weighs in on UW’s current autopsy protocols.

Diagnosing COVID-19: Advice from UW Pathologists on Ramping Up Testing Capacity

CAP in the Media

The CAP has been working proactively to share our members’ expertise.

(please note some links may require subscriptions or may outdate due to host site changes)

How Accurate Are COVID-19 Diagnostic and Antibody Tests?
Healthline - July 8, 2020
President-Elect Emily Volk, MD, MBA, FCAP, and Christina Wojewoda, MD, FCAP, vice chair of the CAP Microbiology Committee, speak on behalf of the CAP on how to conduct different types of COVID-19 tests including the advantages and accuracy of each.

COVID-19 can’t pass the smell test
KABC - July 8, 2020
CAP President-Elect Emily Volk, MD, MBA, FCAP, comments on studies showing that some COVID-19 patients lose their sense of smell, saying viruses can often inflame the olfactory nerves.

Pathologist shares findings from autopsies of COVID-19 patients
MSNBC - July 8, 2020
Mary Elizabeth Fowkes, MD, PhD, FCAP, CAP Governor, discusses what pathologists have learned from autopsies on COVID-19 patients.

As coronavirus surges elsewhere, Nebraska labs report supply shortages, long wait times - July 8, 2020
Deborah Perry, MD, FCAP, comments on COVID-19 testing supply shortages, especially reagents, at her Nebraska hospital laboratory.

Digital pathology to diagnose patients debuts in San Diego
San Diego Community News Group - July 5, 2020
Julie Steele, MD, FCAP, comments on the enhanced use of digital pathology at Scripps MD Anderson Cancer Center.

Samuel K. Caughron: Stop Medicare cuts to pathologists during pandemic
The Topeka Capital-Journal - July 4, 2020
Samuel K. Caughron, MD, FCAP, recounts the essential role of pathologists during the COVID-19 pandemic and warns against scheduled payment cuts to non-evaluation and management services in 2021.

Congress needs to protect physicians from Medicare cuts
The Hill - July 2, 2020
CAP President Patrick Godbey, MD, FCAP, authored this piece that covers the essential role of pathologists and other health professionals during the COVID-19 pandemic and how the federal government has helped support them through telemedicine and Paycheck Protection Program policies. However, the planned January 2021 payment reductions to all non-evaluation and management services is still of serious concern.

With spike in coronavirus infections, demand for COVID-19 testing surges in San Antonio
San Antonio Express-News - June 30, 2020
CAP President-Elect Emily Volk, MD, MBA, FCAP, co-chairs a COVID-19 Community Response Coalition for the San Antonio Area, which plans to survey local testing providers, laboratories, and employers every two weeks to gauge demand for testing.
Note: This article is only available to San Antonio Express-News subscribers.

CAP survey: Labs are high on coronavirus test capacity, but still short of supplies - July 1, 2020
CAP President Patrick Godbey, MD, FCAP, discusses the results of a newly released CAP survey of laboratories in the US.

Autopsies are more important than ever. Here’s what they can tell us.
Popular Science - July 1, 2020
Mary Fowkes, MD, PhD, FCAP, explains how pathologists conduct autopsies and what can be learned from them.
Dr. Fowkes also discussed autopsies in The Washington Post. 

Everyday Heroes: Hospital Laboratory Works Behind the Scenes
The Brunswick News - June 30, 2020
CAP President Patrick Godbey, MD, FCAP, discusses the essential role of medical laboratories during the COVID-19 pandemic: "We’re involved in the care of almost every hospital patient.”

Medical Laboratory Test Data and Clinical Lab 2.0 are Powering Dashboards That Help Providers Mitigate COVID-19 and Improve Population Health
Dark Daily - June 24, 2020
Jordan Olson, MD, FCAP, discusses the use of informatics dashboards in tracking COVID-19 testing data at Geisinger Health System.
This article is further pickup from an April article in 360Dx.

Digitizing And Automating Unsung Heroics: The Case Of Pathology
Forbes - June 23, 2020
Alexander Baras, MD, PhD, FCAP, director of informatics for the department of pathology and the director of precision medicine informatics at Johns Hopkins, discusses the details of digital pathology practice and resulting data. The CAP is also mentioned in regard to its lack of official approval on using AI for image analysis-based diagnosis.

I’m a COVID-19 lab director. This is why the integrity of my testing depends on investment in people
Fast Company - June 18, 2020
Li Jin, MD, PhD, FCAP, authored this article explaining the complexities of COVID-19 testing, the need for laboratory funding, and requirements for highly skilled laboratory professionals.

Galveston Co. provides free antibody tests after COVID-19 spike - June 17, 2020
Michael Laposata, MD, PhD, FCAP, discusses the effectiveness of COVID-19 antibody tests and how he helped select what he sees as the best option for his hospital's patient community.

Harvey Fineberg Reviews the US Pandemic Response
Medscape - June 17, 2020
George Lundberg, MD, FCAP, interviews Harvey Fineberg, MD, PhD, of Harvard's Institute of Medicine on the US response to the COVID-19 pandemic.

Minnesota mass gathering participants eligible for COVID-19 testing
Mayo Clinic News Network - June 16, 2020
Bobbi Pritt, MD, FCAP, highlights the importance of proper follow up and precautions following a COVID-19 test: "Whether your results are positive or negative, it's important that you know so you can take the right steps in stopping the spread of the virus."

What Zebra Mussels Can Tell Us About Errors In Coronavirus Tests
National Public Radio - June 15, 2020
The CAP's COVID-19 proficiency testing is mentioned and Bobbi Pritt, MD, FCAP, chair of the CAP Microbiology Committee, comments on new research on how PCR testing and its use on studying mussels could help reduce false positive tests for COVID-19. Listen to the full radio interview. 

In-house antibody testing now available through University of Iowa Health Care
KWQC-TV6 News - June 15, 2020
Matthew Krasowski, MD, PhD, FCAP, comments on the antibody testing for COVID-19 available at University of Iowa Health Care, but says, "However, it’s important to note that we don’t yet know if antibodies will provide protective immunity against COVID-19.”

Antibody testing for COVID-19 not as helpful as hoped
Pittsburgh Post-Gazette - June 13, 2020
Kymberly Gyure, MD, FCAP, says the current use of antibody testing for COVID-19 is limited, mostly for small epidemiological studies or to use as a screen for plasma donors.

Science in Action: The medical complexity of COVID-19
BBC - June 4, 2020
On the BBC podcast "Science in Action," Mary Fowkes, MD, PhD, FCAP, and member of the CAP Board of Governors, discusses the occurrence of strokes in COVID-19 patients as well as the disruption of the immune system.

Cancer Researchers Have a Head Start in Fight Against COVID-19
Roswellpark - June 3, 2020
Joanne Becker, MD, FCAP, has been leading convalescent plasma treatment for COVID-19 at Roswell Park Comprehensive Cancer Center.

WVU producing swabs for virus testing
Hampshire Review - June 3, 2020
Peter Perrotta, MD, FCAP, comments on the shortages of critical testing supplies and the production of swabs at West Virginia University.

Video and Transcript--Testing, Testing, and More Testing: Newswise Live COVID-19 Expert Panel
Newswise - May 29, 2020
The CAP hosted a virtual news conference on COVID-19 testing featuring Patrick Godbey, MD, FCAP; Bobbi S. Pritt, MD, FCAP; Raouf Nahkleh, MD, FCAP; and Emily Volk, MD, FCAP. The panel discusses the status of testing capacity and the types of tests available including antigen testing.

How many people have coronavirus? Sometimes, it's just a guess - May 26, 2020
Michael Misialek, MD, FCAP, discusses the use of a tracheal aspirate test for making a difficult COVID-19 diagnosis as well as the various factors that can affect testing accuracy.

Here's How to Use Hand Sanitizer the Right Way
InStyle - May 26, 2020
Christina Wojewoda, MD, FCAP, on behalf of the CAP, explains the effectiveness of hand sanitizer on different types of bacteria and viruses.

Clearing confusion
San Antonio Express-News - May 23, 2020
Emily Volk, MD, MBA, FCAP, explains COVID-19 antibody testing in this letter to the editor.

Placenta Injury Observed in Pregnant Women Who Test Positive For Coronavirus
Forbes - May 22, 2020
Jeffrey Goldstein, MD, FCAP, is the lead author of a new study from Northwestern University that found "there might be something clot-forming about coronavirus, and it’s happening in the placenta."

UMMC reaches milestone: 10,000 COVID-19 tests and counting
The Clarion-Ledger - May 22, 2020
Timothy Allen, MD, JD, FCAP, discusses his team's approach to creating an in-house COVID-19 test at the University of Mississippi Medical Center.

Blood Shortage Looms in U.S.
Medpage Today - May 21, 2020
Glenn Ramsey, MD, FCAP, chair of the CAP Transfusion, Apheresis, and Cellular Therapy Committee, discusses the effect of the COVID-19 pandemic on the US blood supply and donors.

Valley doctor says not all coronavirus test sites are ‘legit’ - May 21, 2020
Ravindra Veeramachaneni, MD, FCAP, explains legitimate testing sites for COVID-19, which are officially recognized by the county governments in Texas.

Mayo Clinic doctors find many COVID-19 antibody tests fail their quality standards: ABC News exclusive
ABC News - - May 21, 2020
William Morice, MD, PhD, FCAP, comments on the rushed development and vetting process of COVID-19 antibody tests that may be leading to an increase in unreliable tests on the market.

10 things to know about COVID-19 testing
MD Anderson Cancer Center - May 21, 2020
Micah Bhatti, MD, PhD, FCAP, discusses how COVID-19 testing works, the reliability of at-home tests, and more.

OHSU working toward reliable antibody test
KATU - May 21, 2020
Donna Hansel, MD, PhD, FCAP, discusses antibody test development at Oregon Health and Science University as well as some concerns she has about the tests currently available including how patients understand them.

What You Need to Know About Coronavirus Testing
US News & World Report - May 20, 2020
CAP President Patrick Godbey, MD, FCAP, speaks on behalf of the CAP regarding COVID-19 testing, including the role of antibody testing. convalescent plasma donors, and testing supply shortages.

COVID-19 data chief claims she was fired for refusing to “manipulate data” to back reopening Florida - May 19, 2020
Stephen Nelson, MD, FCAP, comments on claims that Florida officials pressured health care professionals to manipulate numbers related to COVID-19 cases and deaths: "This is no different than any other public record we deal with," he said. "It's paid for by taxpayer dollars, and the taxpayers have a right to know."

How COVID-19 Deaths Are Counted
Scientific American - May 19, 2020
Sally Aiken, MD, FCAP, discusses how medical examiners confirm COVID-19 deaths when cause of death isn't always clear and how the practice supports accurate death counts.

What Tests for COVID-19 Antibodies Can and Can’t Tell Us About the Disease
Healthline - May 14, 2020
Sheldon Campbell, MD, PhD, FCAP, discusses shortcomings of currently available COVID-19 antigen tests

What to Know About Coronavirus Testing
WebMD - May 14, 2020
Gary Procop, MD, MS, FCAP, discusses a study that compared the results and accuracy of five COVID-19 tests and the potential harm caused by false negatives.

How Much Testing Does the U.S. Need to Reopen?
The New Yorker - May 14, 2020
Brian Jackson, MD, FCAP, says that financial uncertainty is one of the major constraints holding back the US testing capacity for COVID-19.

CAP outlines limits of coronavirus serology tests - May 13, 2020
In a statement from CAP President Patrick Godbey, MD, FCAP, the CAP detailed its position on current serology testing, reiterating it is no substitute for nucleic acid tests for making a diagnosis.

Gov. Abbott Said 25,000 COVID-19 Tests By Mid-May. Will That Happen?
KERA News - May 12, 2020
Joe Saad, MD, FCAP, discusses shortages in COVID-19 testing supplies including reagents and viral transport media, the latter of which his laboratory began making on its own.

Labs absorb revenue losses, adapt to a 'new normal' - May 11, 2020
CAP President Patrick Godbey, MD, FCAP; President-Elect Emily Volk, MD, MBA, FCAP; and Jonathan Myles, MD, FCAP, chair of the Council on Government and Professional Affairs discuss the findings of the CAP's survey of US laboratory directors.

SARS-CoV-2 Testing Problems Started Early; US Still Playing From Behind
360Dx - May 11, 2020
CAP President-Elect Emily Volk, MD, MBA, FCAP, discusses COVID-19 testing and how it has improved despite early setbacks. Jordan Laser, MD, FCAP, also comments.
The article also appeared in Modern Healthcare.

COVID-19 test shortages persist in Illinois, crimping plans for return to normal - May 7, 2020
In this TV interview, Patrick Godbey, MD, FCAP, comments on the results of the CAP laboratory survey that showed COVID-19 testing supply shortages in the majority of US laboratories. Karen Kaul, MD, PhD, FCAP, also comments on her laboratory's testing experience.

California's race to conduct as many as 80,000 covid-19 tests every day
MIT Technology Review - May 5, 2020
Christina Kong, MD, FCAP, discusses how laboratories in California are handling COVID-19 testing demand and supply shortages.

VERIFY: Are doctors inaccurately reporting deaths as COVID-19-related
CBS 19 - May 4, 2020
John Wayne, MD, FCAP, explains how death certificates are completed including guidelines for recording COVID-19 deaths.

The Search Is On for America’s Earliest Coronavirus Deaths
The Wall Street Journal - May 4, 2020
James Gill, MD, FCAP, discusses how COVID-19 deaths are identified and what may hamper investigators looking for early cases.

Keeping Pace with the Pandemic
The Pathologist - May 4, 2020
Marisa Saint Martin, MD, FCAP, writes about the importance of mindfulness and meditation during times of crisis and how she has found purpose through her work as a pathologist.

Letters: ‘I do not intend to go to movie theaters, restaurants’
Houston Chronicle - May 4, 2020
In this letter to the editor, Abdul Abid, MD, MBBS, CAP Junior Member and member of the CAP Engaged Leaders Network, explains the essential role of pathologists during the pandemic.

Team effort makes free COVID-19 testing site in southwest Little Rock a success - May 2, 2020
Jennifer Hunt, MD, FCAP, member of the CAP Engaged Leaders Network, oversaw a drive-through COVID-19 testing site organized by the University of Arkansas for Medical Sciences.

Newsviews: Dr. Karen Kaul - May 3, 2020
Karen Kaul, MD, PhD, FCAP, discusses the NorthShore University HealthSystem early COVID-19 test development and their implementation of antibody testing.

AMP, CAP, Others Request Medicare Coverage for Respiratory Panel Tests
360Dx - April 30, 2020
The CAP, along with five other medical organizations, submitted a letter to the Centers for Medicare and Medicaid Services advocating for national coverage for multiplex respiratory viral panel tests.

CDC: Coronavirus and other causes behind increase in deaths in U.S. - April 30, 2020
Sally Aiken, MD, FCAP, and James Gill, MD, FCAP, comment on tracking the number of deaths linked to COVID-19 and recommend saving samples of the deceased for future testing when more supplies are available.

Autopsies provide crucial information for fighting COVID-19
Popular Science - April 30, 2020
Alex Williamson, MD, FCAP, member of the CAP's Autopsy Committee, discusses the crucial role of medical examiners and autopsies in learning more about COVID-19.

Testing an Old Therapy Against a New Disease: Convalescent Plasma for COVID-19
The JAMA Network - April 30, 2020
Beth Shaz, MD, FCAP, discusses the effectiveness of convalescent plasma treatment for COVID-19.

Oh! So THAT’s what a pathologist does during the coronavirus pandemic
Miami Herald - April 29, 2020
Khaled Algashaamy, MD, CAP Junior Member, and member of the Engaged Leaders Network, authored this article that highlights and explains the role of pathologists during a pandemic while detailing how the laboratories at the University of Miami developed and implemented COVID-19 testing.

How accurate is the US coronavirus death count? Some experts say it's off by 'tens of thousands'
ABC News - - April 29, 2020
On behalf of the CAP, Alex Williamson, MD, FCAP, comments on the need for more testing to determine the overall impact of the COVID-19 pandemic.

Chicago doctor who treated coronavirus in Wuhan says lessons learned offer hope for Illinois - April 28, 2020
Shu-Yuan Xiao, MD, FCAP, recounts his experience in Wuhan at the outbreak of COVID-19 and comments on the spread of the disease in the US and Chicago where he works at the University of Chicago.

Telepathology: Part 2 -- Putting plans into action - April 27, 2020
Jesus Chavez, MD, CAP Junior Member; Zoltan Laszik, MD, PhD, FCAP; and Giovanni Lujan, MD, FCAP, discuss the successes and challenges of working remotely and how best to implement digital pathology.

Pathologists Hunt for Earlier Coronavirus Cases in New York
The Wall Street Journal - April 27, 2020
Alain Borczuk, MD, FCAP, and his team at Weill Cornell Medicine are trying to determine if deaths before March in New York might have been initially undetected COVID-19 cases.

1,000 Boston residents to be randomly tested for COVID-19 antibodies in hard-hit neighborhoods
WHDH-TV - April 27, 2020
David Louis, MD, FCAP, says randomized COVID-19 testing in Boston “will also give us information on things like whether someone is ready to go back to work potentially, and it will also give us information on understanding what it means to be immune.”

Telepathology: Part 1 -- COVID-19 gives home working a push - April 26, 2020
Eric Glassy, MD, FCAP, discusses effective digital pathology practice for those pathologists working remotely after the temporary waiver from the federal government.

Questions about COVID-19 tests persist in Crossroads, across county
Victoria Advocate - April 25, 2020
Leilani Valdes, MD, FCAP, chair of the CAP Professional and Community Engagement Committee and member of the Engaged Leaders Network, discusses the effectiveness and limitations of COVID-19 testing.

Utah And New Mexico Lead The Region In COVID-19 Testing. Here's How They've Done It
KUNC - April 24, 2020
Richard Scanlan, MD, FCAP, chair of the CAP Council on Accreditation, comments on the relative success of COVID-19 testing at laboratories in Utah and New Mexico.

1 in 5 New Yorkers May Have Had Covid-19, Antibody Tests Suggest
The New York Times - April 23, 2020
Joan Cangiarella, MD, FCAP, is skeptical about the effectiveness of antibody testing, saying more data is needed to determine effectiveness and immunity to COVID-19.

Liron Pantanowitz: The importance of digital pathology
Pittsburgh Post-Gazette - April 23, 2020
In this letter to the editor, Liron Pantanowitz, MD, FCAP, explains the essential role of pathologists during the COVID-19 pandemic as well as the importance of reliable digital pathology systems.

Letter: Laboratory professionals dedicated to fighting virus
St. Louis Post-Dispatch - April 23, 2020
In light of National Medical Laboratory Professionals Week, Christopher O’Conor, MD, PhD, CAP Junior Member, authored this letter to the editor highlighting pathologists, laboratory professionals, and the essential work they do in the laboratory during the COVID-19 pandemic.

At-home testing kits for COVID-19 may soon be hitting the market
WFXT FOX Boston 25 News - April 23, 2020
In this TV interview, Michael Misialek, MD, FCAP, explains COVID-19 at-home testing and antibody testing, and whether the presence of antibodies in a patient indicates immunity.

FDA approves at-home COVID-19 test - April 21, 2020
Bobbi Pritt, MD, FCAP, explains a new FDA approved at-home COVID-19 test.

F.D.A. Approves First In-Home Test for Coronavirus
The New York Times - April 21, 2020
Sheldon Campbell, MD, PhD, FCAP, comments on in-home COVID-19 testing and how it could help patients with mobility difficulties and support telemedicine initiatives.

What will it take to have adequate virus testing?
WCAX-TV CBS - April 21, 2020
Christina Wojewoda, MD, FCAP, explains the COVID-19 testing process at University of Vermont Medical Center, the sensitivity of different tests, and supply shortages.

Letters to the Editor - Lab technicians
The Dallas Morning News - April 19, 2020
Assad Joe Saad, MD, FCAP, and member of the CAP's Engaged Leaders Network, authored this letter to the editor that explains laboratory testing and highlights the role of the pathologist during the COVID-19 pandemic and National Medical Laboratory Professionals Week.

The unsung heroes of the coronavirus battle: laboratory technicians
Hartford Courant - April 18, 2020
Sheldon Campbell, MD, PhD, FCAP, coauthored this article that highlights the essential role of laboratory professionals, especially during the COVID-19 pandemic.

Test troubles cloud Trump recovery effort
PBS NewsHour - April 17, 2020
Meghan Delaney, DO, MPH, FCAP, comments on the shortage of reagents that is hampering COVID-19 testing efforts in her laboratory at Children's National Hospital.

Rapid coronavirus test, commonly used in US, may miss infections in some situations
CNBC - April 16, 2020
Michael Misialek, MD, FCAP, discusses the reported shortcomings and overall effectiveness of the new rapid coronavirus test.

Last responders: The grim job of medical examiners in the COVID-19 pandemic
ABC News - - April 16, 2020
Angela N. Baldwin, MD, CAP Junior Member, authored this piece profiling the role of medical examiners during a pandemic.

Coronavirus tests for antibodies coming, but public health experts question accuracy - April 15, 2020
Karen Kaul, MD, PhD, FCAP, discusses serological tests, their reliability, and their accuracy.

Antibody Tests For Coronavirus Can Miss The Mark
National Public Radio - April 15, 2020
Jordan Laser, MD, FCAP, comments on the usefulness and specificity of new antibody tests to determine patients' COVID-19 immune status.

Daily virtual lectures meet pathology residents where they are - April 14, 2020
Christina Arnold, MD, FCAP, discusses the CAP's free online lecture series geared toward pathology residents who may be missing educational opportunities due to the pandemic.

Test makers, FDA struggling with shift from molecular to serology testing for SARS-CoV-2
BioWorld - April 14, 2020
Christina Wojewoda, MD, FCAP, discusses the viability of serology testing in assessing the current and future spread of the COVID-19 pandemic.

Dr. Marc Siegel takes rapid COVID-19 test live on 'Tucker Carlson Tonight'
Fox News - April 13, 2020
Michael Misialek, MD, FCAP, conducts a rapid COVID-19 test on medical correspondent Marc Siegel, MD, during a live interview on the cable news network.

Delayed coronavirus test results strain Washington’s resources and leave patients in limbo
The Seattle Times - April 8, 2020
Eric Konnick, MD, MS, FCAP, comments on the difference in test cost among various types of laboratories.

Coronavirus deaths may be undercounted in Alabama, doctors say - April 8, 2020
Randy Hanzlick, MD, FCAP, provides background on autopsies, cause of death, and death certificates and how those might affect tracking COVID-19 deaths.

White House Adviser Kudlow: Looking to reopen economy as soon as health experts give green light
Yahoo! Finance - April 7, 2020
Roger Klein, MD, JD, FCAP, discusses COVID-19 testing, the spread of the pandemic, and implications on the duration of the crisis in this video interview.

Delays and Shortages Exacerbate Coronavirus Testing Gaps in the U.S.
The New York Times - April 7, 2020
Elaine Cham, MD, FCAP, discusses her laboratory's experience with COVID-19 testing and some of the challenges brought about by supply shortages and long turnaround times.

Shortage of Test Components Forces Labs to Beg, Borrow and Improvise - April 5, 2020
Joan Cangiarella, MD, FCAP, discusses how the laboratory at NYU Langone Health is obtaining necessary laboratory testing materials

Lab workers are unseen warriors fighting the coronavirus
ABC News - - April 4, 2020
Timothy Allen, MD, JD, FCAP, and Kathleen Beavis, MD, FCAP, speak on behalf of the CAP when discussing the essential work being done by pathologists and laboratory professionals during the COVID-19 pandemic. CAP Junior Member Angela Baldwin, MD, authored the article.

Cook County medical examiner searching for warehouse as it braces for more coronavirus deaths. ‘We want to treat the deceased with the respect they deserve’
Chicago Tribune - April 1, 2020
Sally Aiken, MD, FCAP, comments on autopsy guidelines and best practices in light of an increased demand during the COVID-19 pandemic.

'This Is Truly a Last Resort.' Makers Are 3D Printing Ventilator Parts and Sewing Masks Amid a Critical Shortage in Medical Supplies
Time Magazine - April 1, 2020
Guillermo Tearney, MD, PhD, FCAP, is part of a team investigating alternative supplies in preparation for shortages during the COVID-19 pandemic.

Performing the coronavirus test: ‘a tennis ball that doesn’t bounce straight’
Arkansas Times - March 31, 2020
Jennifer Hunt, MD, FCAP, explains how COVID-19 testing works, including some of the challenges laboratories are facing.

Post-Op HPV Vaccine Cuts Cervical Precancer Recurrences
Medpage Today - March 31, 2020
Cornelia Trimble, MD, FCAP, comments on the effectiveness of HPV vaccines after patients have undergone surgery for high-grade cervical intraepithelial neoplasia.

Cambridge biotech seeks OK for coronavirus test that delivers results in 15 minutes
The Boston Globe - March 31, 2020
David Louis, MD, FCAP, comments on newly developed rapid tests for COVID-19.

More on stimulus' health tech boosts
Politico - March 30, 2020
Coverage of the CAP's advocacy work with CMS for a temporary waiver giving pathologists the flexibility needed to work remotely during the COVID-19 pandemic.

Labs scrambling to test for COVID-19 face same obstacle: Not enough supplies
The Buffalo News - March 30, 2020
John Tomaszewski, MD, FCAP, discusses the shortage of testing supplies facing many laboratories.

UMMC begins in-house testing for COVID-19
WJTV News Channel 12 - March 27, 2020
Timothy Allen, MD, JD, FCAP, discusses the University of Mississippi Medical Center (UMMC) laboratory's COVID-19 testing validation and implementation.

Some Chicagoans report lengthy delays on coronavirus test results: More than a week later, ‘I still have nothing’
The Chicago Tribune - March 27, 2020
Karen Kaul, MD, PhD, FCAP, describes the process for COVID-19 testing at NorthShore University HealthSystem.

Cough, Fever, Fatigue? Head to CDC's Online Coronavirus Symptom Checker
US News & World Report - March 27, 2020
Gary Procop, MD, FCAP, comments on the usefulness of the CDC's online coronavirus symptom tracker in helping to alleviate hospital overcrowding and manage patients.

Promising new 15-minute test for coronavirus comes with caveats
ABC News - March 26, 2020
Bobbi Pritt, MD, FCAP, explains the types of testing being done for COVID-19 as well as test development and availability. The article is authored by Angela Baldwin, MD, CAP Junior Member, and a member of the ABC News Medical Unit.

Mayo shifts into overdrive: 24 hours a day, 4,000 tests and climbing - March 25, 2020
Bobbi Pritt, MD, FCAP, discusses the challenges faced by laboratories and health care professionals during the COVID-19 pandemic, as well as Mayo Clinic's efforts to increase testing.

Start-Ups Jump the Gun on Home Kits for Coronavirus Testing
The New York Times - March 23, 2020
Sheldon Campbell, MD, PhD, FCAP, voices concern over direct-to-consumer tests for COVID-19.

The standard coronavirus test, if available, works well—but can new diagnostics help in this pandemic?
Science - March 22, 2020
Benjamin Pinsky, MD, PhD, FCAP, comments on supply shortages and other issues laboratories are facing with COVID-19 testing.

Inside the South Korean Labs Churning Out Coronavirus Tests
The Wall Street Journal - March 19, 2020
Alex Greninger, MD, PhD, FCAP, comments on his University of Washington laboratory's rush to find live virus samples when developing COVID-19 tests before the disease began spreading in the region.

So far, so good for pregnant women with SARS-CoV-2 - March 19, 2020
Further coverage of a new study in the CAP's Archives of Pathology & Laboratory Medicine, authored by David A. Schwartz, MD, FCAP. that found no apparent transfer of COVID-19 between mother and fetus.

What to know about social distancing strategies amid coronavirus outbreak - March 19, 2020
Angela Baldwin, MD, CAP Junior Member, member of the ABC News Medical Unit, answers common questions and explains effective social distancing in relation to COVID-19.

How Washington Failed to Build a Robust Coronavirus Testing System
The Wall Street Journal - March 18, 2020
Richard Scanlan, MD, FCAP, comments on the high demand and supply for COVID-19 testing.

Infants Born to Mothers With COVID-19 Appear Healthy
Medscape - March 17, 2020
The CAP's Archives of Pathology & Laboratory Medicine will publish an analysis of pregnant women with COVID-19 and the health of their infants, authored by David A. Schwartz, MD. FCAP.

WGN News at Ten
WGN - March 17, 2020
Karen Kaul, MD, PhD, FCAP, discusses COVID-19 test development, criteria, turnaround time, and supplies after her team at NorthShore University HealthSystem implemented testing. Watch the interview.

Testing criteria for COVID-19 is critical
WIBW 13 News - March 17, 2020
Richard Gomez, MD, FCAP, discusses the criteria for COVID-19 testing considering patients' risk, exposure, and condition.

Coronavirus Test Developed, And Available, At Evanston Hospital, With Results In Just Hours
CBS Chicago - March 16, 2020
Karen Kaul, MD, PhD, FCAP, discusses the rapid development and implementation of COVID-19 testing at NorthShore University HealthSystem.

For Patients

The CAP provides this easy to view table: Clarifying Tests for COVID-19

The CDC provides information related to the prevention and treatment of COVID-19.

Learn more about pathologists and their critical role on the health care team.

For Media

For inquiries related to laboratory medicine and the pathologists’ role in COVID-19, please contact